Halozyme COVID-19 Response
Homepage

Science

ENHANZE® Technology

HYLENEX® recombinant

(hyaluronidase human injection)

Careers

Investors

About Us

Useful Links

Contact Info


Office:

Halozyme
11388 Sorrento Valley Road
San Diego, CA 92121
Phone: 858.794.8889
info@halozyme.com

Recent News

January 15, 2021 Halozyme Announces Janssen Receives FDA Approval Of DARZALEX FASPRO® (Daratumumab And Hyaluronidase-fihj) As Treatment For Newly Diagnosed Patients With Light Chain (AL) Amyloidosis
January 11, 2021 Halozyme Provides 2021 Financial Guidance Highlighted By Strong Revenue And EPS Growth
January 4, 2021 Halozyme To Present Virtually At The 39th Annual J.P. Morgan Healthcare Conference
Copyright© 2015-2019. Halozyme, Inc. All rights reserved. All trademarks belong to their respective owners.
Powered By Q4 Inc. 5.50.0.4

Notice

You are now leaving Halozyme.com. Halozyme is not responsible for or endorses the content of the linked site.

Ok